Pharmafile Logo
Pharmafocus logo
Advanced Search

Almirall

Showing 10 posts of 25 posts found.

Almirall welcomes UCB head into Board of directors

October 29, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Almirall, Gerhard Mayr

Almirall has approved the appointment of Gerhard Mayr as a new independent member to its Board of directors. He is …

Appointment
Eklira image

Almirall’s COPD drug launched in Europe

September 20, 2012
Sales and Marketing Advair, Almirall, Eklira, Genuair, Seretide, Spiriva

Almirall has launched COPD treatment Eklira in Denmark following approval from the European Commission. Phase III trials demonstrated that Eklira …

News

Working Life: Carlos Gallardo, general manager, Almirall

February 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …

Feature

Almirall appoints new general manager for Germany

July 1, 2011
Research and Development, Sales and Marketing Almirall, appointment, research and development, sales and marketing

Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …

News

Bertil Lindmark joins Almirall as R&D head

January 27, 2011
Research and Development Almirall, Bertil Lindmark, appointment, research and development

Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …

Appointment

Almirall and Forest’s phase III COPD drug misses goal

November 3, 2010
Research and Development Aclidinium bromide, Almirall, COPY, Forest, Forest Laboratories, chronic obstructive pulmonary disease

Almirall and Forest’s COPD drug aclidinium bromide has disappointed in a phase III trial by producing fewer benefits than found …

News

Positive results for irritable bowel syndrome drug

September 14, 2010
Research and Development Almirall, IBS, linaclotide

A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …

News

Almirall opens UK headquarters

May 27, 2009
Sales and Marketing Almirall

Spanish pharma company Almirall has opened its new UK and Ireland headquarters in West London's Stockley Park.The site will be …

News

Almirall in talks with potential asthma partners

February 26, 2009
Sales and Marketing Almirall, COPD

Spanish pharma company Almirall is in discussions with potential partners for one of its asthma drugs following positive trial results. …

News

Almirall expands its horizons

July 3, 2008
Research and Development, Sales and Marketing Almirall, COPD, Spain

Almirall has been Spain's number one pharmaceutical company for some years, but is still little known outside its home market. …

Feature

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024